{"disease":{"id":"monogenic-obesity","name":"monogenic obesity"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06380426","title":"Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)","phase":"","overall_status":"RECRUITING","enrollment_count":175,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05362565","title":"Genetic Research of Monogenic Obesity in a Pediatric Cohort With Severe and Early Onset Obesity","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07220772","title":"A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":4,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04710056","title":"Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}